James Kehoe - Walgreens Boots Global CFO, Executive Vice President - Global
| WBA Stock | USD 9.02 0.04 0.44% |
President
Mr. James Kehoe is Global Chief Financial Officer, Executive Vice President of the Company. Kehoe was chief financial officer of Takeda Pharmaceutical since June 2016 and was based in Tokyo, reporting directly to the company president and CEO. He was appointed to the Takeda Pharmaceutical board of directors in June 2017. Kehoe is an accomplished finance executive from the consumer goods sector and a strong business leader with a track record of driving operational business performance. He joined Takeda Pharmaceutical from Kraft Foods Group in the U.S., where he last held the role of executive vice president, chief financial officer. Prior to that, he held a number of financerelated positions over 25 years with assignments based in Ireland, Germany, Italy, U.S., Austria, Switzerland and Canada. since 2019.
| Age | 62 |
| Tenure | 5 years |
| Address | 108 Wilmot Road, Deerfield, IL, United States, 60015 |
| Phone | 847 315 3700 |
| Web | https://www.walgreensbootsalliance.com |
James Kehoe Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Kehoe against Walgreens Boots stock is an integral part of due diligence when investing in Walgreens Boots. James Kehoe insider activity provides valuable insight into whether Walgreens Boots is net buyers or sellers over its current business cycle. Note, Walgreens Boots insiders must abide by specific rules, including filing SEC forms every time they buy or sell Walgreens Boots'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Kehoe over three months ago Disposition of 35137 shares by James Kehoe of Fidelity National at 78.7 subject to Rule 16b-3 |
Walgreens Boots Management Efficiency
The current year's Return On Tangible Assets is expected to grow to -0.16. The current year's Return On Capital Employed is expected to grow to -0.25. At present, Walgreens Boots' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 65.8 B, whereas Total Current Assets are forecasted to decline to about 9.5 B. Walgreens Boots' management efficiency ratios could be used to measure how well Walgreens Boots manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | PRESIDENT Age | ||
| Peter Lee | Leafly Holdings | 47 | |
| Byron Finn | SunLink Health Systems | 68 | |
| Sheila Brockman | SunLink Health Systems | 64 | |
Management Performance
| Return On Equity | -0.76 | ||||
| Return On Asset | 0.0059 |
Walgreens Boots Alliance Leadership Team
Elected by the shareholders, the Walgreens Boots' board of directors comprises two types of representatives: Walgreens Boots inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Walgreens. The board's role is to monitor Walgreens Boots' management team and ensure that shareholders' interests are well served. Walgreens Boots' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Walgreens Boots' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Amsbary, Senior Secretary | ||
| James Kehoe, Global CFO, Executive Vice President - Global | ||
| Lanesha JD, Executive Officer | ||
| Holly May, Ex Officer | ||
| Beth Leonard, Senior Officer | ||
| Timothy Wentworth, CEO Director | ||
| Stefano Pessina, Executive Vice Chairman and CEO | ||
| Matthew DAmbrosio, Senior Officer | ||
| Rick Gates, Senior Co | ||
| Neal Sample, Executive Officer | ||
| Gerald Gradwell, IR Contact Officer | ||
| Rosalind Brewer, CEO Director | ||
| Tracey Brown, President VP | ||
| Hsiao Wang, VP Officer | ||
| Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail | ||
| Mia Scholz, Sr Operations | ||
| John Driscoll, Executive Healthcare | ||
| Tiffany Kanaga, Vice Relations | ||
| Liyue Wu, Head Asia | ||
| Danielle Gray, Ex Officer | ||
| Manmohan Mahajan, Executive CFO | ||
| Todd Heckman, Interim VP | ||
| Lanesha Minnix, Executive Officer | ||
| Aaron Radelet, Global VP | ||
| Natasha Polster, Compliance Quality | ||
| Aidan Clare, Senior Treasurer | ||
| Elizabeth Burger, Executive Officer |
Walgreens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Walgreens Boots a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.76 | ||||
| Return On Asset | 0.0059 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 37.54 B | ||||
| Shares Outstanding | 864.62 M | ||||
| Shares Owned By Insiders | 17.66 % | ||||
| Shares Owned By Institutions | 61.77 % | ||||
| Number Of Shares Shorted | 100.79 M | ||||
| Price To Earning | 8.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.915 | Dividend Share 1.23 | Earnings Share (10.01) | Revenue Per Share 171.079 | Quarterly Revenue Growth 0.06 |
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.